Wogonoside Mitigates Inflammation and Cell Proliferation via Modulation of NF-κB Signalling Pathway in DMBA-Induced Mammary-Preclinical Model
Chenyang He1, Yu Zhang1, Yan Diao1, Xingcong Ma1, Guochao Mao1, Xinyu Wei1, Yang Zhao1★★ Corresponding author
- 1The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, CHINA.
CORRESPONDENCE
Yang Zhao
The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, CHINA.
Received: 18-03-2025; Revised: 24-05-2025; Accepted: 03-07-2025.
Volume 59, Issue 4 · pp. 1466–1473 · PUBLISHED 2025 · DOI: 10.5530/ijper.20256082
ABSTRACT
Objectives: To hypothesis the effect of wogonoside against DMBA-induced Breast Cancer (BC) via TNF-α induced NF-κB signaling pathway a molecular appraoch. Materials and Methods: A 25 mg/kg Body Weight (BW), DMBA mixed dosage was used to produce BC with 1 mL olive oil by subcutaneous injection. We observed reduced body weight, elevated hepatic marker (AST, ALP, ACP and ALT), phase I (Cyt-b5 and Cyt-p450) and lipid peroxidative (TBARS and LOOH) markers and reduced antioxidant and xenobiotic enzymes in DMBA induced cancer-bearing rats. Moreover, the molecular study revealed that up-regulation of, inflammatory (NF-κB p65, TNF-α, IL-6 and IL-1β) markers in DMBA treated cancer-bearing animals. Results: Oral supplementation of wogonoside substantially reverted back to normal levels of these DMBA-induced rats have biochemical and molecular indicators. Conclusion: Overall, these findings supported wogonoside anti-inflammatory and anti-cell proliferation activity against DMBA-induced breast cancer through modification of the NF-κB signaling pathway.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
He, C., Zhang, Y., Diao, Y., Ma, X., Mao, G., Wei, X., & Zhao, Y. (2025). Wogonoside Mitigates Inflammation and Cell Proliferation via Modulation of NF-κB Signalling Pathway in DMBA-Induced Mammary-Preclinical Model. Indian Journal of Pharmaceutical Education and Research, 59(4), 1466–1473. https://doi.org/10.5530/ijper.20256082
